Getinge Group’s business area Infection Control, a global leader in infection control and contamination prevention solutions, has acquired Stericool, a Turkish company specializing in low temperature sterilization, and also signed an exclusive global distribution agreement with Canadian company TSO3 Inc., an innovator in sterilization technology for medical devices. The acquisition and distribution agreement are in line with Getinge’s strategy to strengthen customer offerings with new innovations and to offer a product range for different markets.

“Today’s announcement marks a major milestone in Getinge’s latest offerings to our customers. As a global leader in infection control, Getinge has a unique opportunity not only to enter into the fast growing low temperature sterilization market, but also to leverage our legacy of excellence as a complete solutions provider,” says Joacim Lindoff, Executive Vice President of Infection Control.

The minimally invasive surgery (MIS) market is a leading indicator of growth for the low temperature sterilization market. The instruments used in such surgeries are extremely sensitive to the high temperatures and pressure of a steam sterilization process. As the minimally invasive surgery market continues to grow at an expected compound annual growth rate of 10 %*, demands for alternatives to steam sterilizers will also increase thereby providing great potential for accelerated business growth within infection control. Estimation on the annual replacement and new business worldwide for low temperature sterilizers totals more than 2,300 units or approximately 1,7 BSEK.